We are live on ! Find out more
VMD icon

Viemed Healthcare

121 hedge funds and large institutions have $186M invested in Viemed Healthcare in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 41 increasing their positions, 26 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

211% more call options, than puts

Call options by funds: $59K | Put options by funds: $19K

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

58% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 26

40% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 15

11% more capital invested

Capital invested by funds: $167M → $186M (+$19M)

4% more funds holding

Funds holding: 116121 (+5)

0.57% less ownership

Funds ownership: 65.49%64.92% (-0.57%)

Holders
121
Holders Change
+5
Holders Change %
+4.31%
% of All Funds
1.74%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
21
Increased
41
Reduced
26
Closed
15
Calls
$59K
Puts
$19K
Net Calls
+$40K
Net Calls Change
+$122K
Name Holding Trade Value Shares
Change
Change in
Stake
LPL Financial
26
LPL Financial
California
$1.41M +$21.4K +3,000 +2%
Russell Investments Group
27
Russell Investments Group
United Kingdom
$1.16M +$45.8K +6,412 +4%
SFM
28
Spartan Fund Management
Canada
$1.1M
Morgan Stanley
29
Morgan Stanley
New York
$1.06M -$897K -125,554 -47%
AE
30
AMH Equity
New York
$1.02M +$992K +138,900 New
N
31
Nuveen
North Carolina
$975K -$242K -33,880 -20%
First Trust Advisors
32
First Trust Advisors
Illinois
$869K +$847K +118,614 New
First Eagle Investment Management
33
First Eagle Investment Management
New York
$813K +$792K +110,901 New
Victory Capital Management
34
Victory Capital Management
Texas
$795K +$684K +95,706 +748%
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$757K +$711K +99,587 +2,722%
Charles Schwab
36
Charles Schwab
California
$728K
JP Morgan Chase
37
JP Morgan Chase
New York
$724K +$425K +59,538 +152%
PCM
38
Perritt Capital Management
Illinois
$623K +$42.9K +6,000 +8%
Boston Partners
39
Boston Partners
Massachusetts
$579K +$8.54K +1,196 +2%
RC
40
RBF Capital
California
$567K
Two Sigma Investments
41
Two Sigma Investments
New York
$544K -$159K -22,205 -23%
VCP
42
Verus Capital Partners
Arizona
$529K +$5.36K +750 +1%
SIC
43
Salem Investment Counselors
North Carolina
$528K
Bank of New York Mellon
44
Bank of New York Mellon
New York
$527K -$168K -23,454 -25%
WG
45
Winton Group
United Kingdom
$455K -$155K -21,678 -26%
SO
46
STRS Ohio
Ohio
$446K
SRCM
47
Sage Rock Capital Management
New York
$435K +$52.1K +7,300 +14%
Barclays
48
Barclays
United Kingdom
$392K +$295K +41,358 +342%
Two Sigma Advisers
49
Two Sigma Advisers
New York
$358K -$119K -16,600 -25%
GF
50
Gabelli Funds
New York
$336K +$328K +45,857 New

VMD Hedge Fund Activity: Q3 2024 in Review

121 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q3 2024, worth a combined $186M — up 11% from $167M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new VMD positions and 15 closed out — a net gain of 6 holders — while 41 added to existing stakes and 26 trimmed.

The largest buyer was Divisadero Street Capital Management, opening a new position worth an estimated $2.5M. The largest seller was AWM Investment Company, cutting an estimated $4.84M.

  • 121 institutional investors held Viemed Healthcare (VMD) as of Q3 2024, up from 116 in Q2 2024.
  • Funds reported $186M of Viemed Healthcare stock for Q3 2024, up 11% quarter-over-quarter.
  • 21 funds opened new Viemed Healthcare positions in Q3 2024 and 15 closed out, a net change of +6 holders.
  • The largest Viemed Healthcare buyer in Q3 2024 was Divisadero Street Capital Management, an estimated $2.5M added.
  • The largest Viemed Healthcare seller in Q3 2024 was AWM Investment Company, an estimated $4.84M sold.

Based on aggregated 13F filings for Q3 2024.